Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Volkin

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
Journal of Pharmaceutical Sciences|November 15, 2008
Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage formPei Qi, David B Volkin, Hui Zhao, et al.
Journal of Pharmaceutical Sciences|March 11, 2015
Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sortingSrivalli Telikepalli, Heather E Shinogle, Prem S Thapa, et al.
Journal of Pharmaceutical Sciences|April 27, 2013
Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometryPrakash Manikwar, Ranajoy Majumdar, John M Hickey, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Development of stable liquid formulations for adenovirus-based vaccinesRobert K Evans, Denise K Nawrocki, Lynne A Isopi, et al.
Microbiology Spectrum|March 25, 2025
Antibody signatures elicited by potent and subpotent whole-cell pertussis vaccines in miceYetunde Adewunmi, Jennifer Doering, Prashant Kumar, et al.
Vaccine|August 24, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Journal of Pharmaceutical Sciences|November 4, 2014
Characterization of an oncolytic herpes simplex virus drug candidateOzan S Kumru, Sangeeta B Joshi, Prem Thapa, et al.
Immunohorizons|February 16, 2019
Fine-Specificity Epitope Analysis Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal AntibodiesGreta Van Slyke, Siva Krishna Angalakurthi, Ronald T Toth, et al.
Human Vaccines & Immunotherapeutics|April 9, 2013
Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigenJustin C Thomas, Joanne M O'Hara, Lei Hu, et al.
Biotechnology and Bioengineering|March 17, 2023
Minimal purification method enables developability assessment of recombinant proteinsSergio A Rodriguez-Aponte, Christopher A Naranjo, Ryan S Johnston, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Journal of Pharmaceutical Sciences|November 15, 2008
Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage formPei Qi, David B Volkin, Hui Zhao, et al.
Journal of Pharmaceutical Sciences|March 11, 2015
Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sortingSrivalli Telikepalli, Heather E Shinogle, Prem S Thapa, et al.
Journal of Pharmaceutical Sciences|April 27, 2013
Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometryPrakash Manikwar, Ranajoy Majumdar, John M Hickey, et al.
Journal of Pharmaceutical Sciences|September 7, 2004
Development of stable liquid formulations for adenovirus-based vaccinesRobert K Evans, Denise K Nawrocki, Lynne A Isopi, et al.
Microbiology Spectrum|March 25, 2025
Antibody signatures elicited by potent and subpotent whole-cell pertussis vaccines in miceYetunde Adewunmi, Jennifer Doering, Prashant Kumar, et al.
Vaccine|August 24, 2023
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell linesOzan S Kumru, Mrinmoy Sanyal, Natalia Friedland, et al.
Journal of Pharmaceutical Sciences|November 4, 2014
Characterization of an oncolytic herpes simplex virus drug candidateOzan S Kumru, Sangeeta B Joshi, Prem Thapa, et al.
Immunohorizons|February 16, 2019
Fine-Specificity Epitope Analysis Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal AntibodiesGreta Van Slyke, Siva Krishna Angalakurthi, Ronald T Toth, et al.
Human Vaccines & Immunotherapeutics|April 9, 2013
Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigenJustin C Thomas, Joanne M O'Hara, Lei Hu, et al.
Biotechnology and Bioengineering|March 17, 2023
Minimal purification method enables developability assessment of recombinant proteinsSergio A Rodriguez-Aponte, Christopher A Naranjo, Ryan S Johnston, et al.
Pageof 18